Product Information
CIPROFLOXACIN HCL 250 MG TAB is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0886 per EA under NDC 16252051401. Its NADAC has been published 645 times since Nov 28, 2013.
FDA first approved this application on Jun 9, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
16252051401
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
3/18/2026
Active Ingredients
CIPROFLOXACIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076794FDA Approved
6/9/2004
TE Code
AB
On Market Since
11/1/2006
Pharmacological Classes
Price Statistics
The NADAC for CIPROFLOXACIN HCL 250 MG TAB has been published 645 times since Nov 28, 2013, and over the history we have for it it has declined 30.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0886 per EA |
|---|---|
| All-time high | $0.1749 (Jun 10, 2015) |
| All-time low | $0.0811 (Nov 20, 2024) |
| 52-week high | $0.0917 |
| 52-week low | $0.0871 |
| Median price | $0.0997 |
| Average price | $0.1095 |
| Largest weekly change | -21.4% (Apr 17, 2024) |
| Weeks tracked | 645 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
+1.6%
1Y
-3.4%
3Y
-10.8%
5Y
-17.8%
All
-30.3%
Last surveyed Apr 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CIPROFLOXACIN HCL 250 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for CIPROFLOXACIN HCL 250 MG TAB, manufactured by Teva Pharmaceuticals USA Inc., is $0.0886 per EA (NDC 16252051401), effective Apr 1, 2026.
How has the price of CIPROFLOXACIN HCL 250 MG TAB changed over time?
Over the history we have for it, the NADAC for CIPROFLOXACIN HCL 250 MG TAB has declined 30.3%. It has been tracked across 645 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CIPROFLOXACIN HCL 250 MG TAB?
Since Nov 28, 2013, the NADAC for CIPROFLOXACIN HCL 250 MG TAB has ranged from a low of $0.0811 (Nov 20, 2024) to a high of $0.1749 (Jun 10, 2015), with a median of $0.0997 per EA.
Are there cheaper alternatives to CIPROFLOXACIN HCL 250 MG TAB?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CIPROFLOXACIN HCL 250 MG TAB, is $0.0880 per EA — about 1% below CIPROFLOXACIN HCL 250 MG TAB.
Who manufactures CIPROFLOXACIN HCL 250 MG TAB?
CIPROFLOXACIN HCL 250 MG TAB (NDC 16252051401) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.